Remove resources case-studies
article thumbnail

January 22, 2024: Your Pragmatic Trial Has Ended. Now What?

Rethinking Clinical Trials

What happens to a pragmatic trial intervention after the study ends? Effective interventions may not be sustained if they require significant resources. The case studies in the article are from the ABATE Infection, LIRE, PPACT, PROVEN, STOP-CRC, and TSOS trials. Read the full article.

Trials 152
article thumbnail

January 8, 2024: Pragmatic Trials Researchers Share Lessons From Collecting Patient-Reported Outcomes in the Electronic Health Record

Rethinking Clinical Trials

In a new article from the NIH Pragmatic Trials Collaboratory, investigators from 6 of the program’s pragmatic clinical trials share case examples of the challenges they encountered in collecting patient-reported outcomes (PROs) in their trials and the strategies they used to address them.

Trials 286
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Case Study: How to generate publishable data in just 12 weeks

Drug Discovery World

The post Case Study: How to generate publishable data in just 12 weeks appeared first on Drug Discovery World (DDW). How this dramatically short experimental research timeline has been driven by the lab’s adoption of precision reprogrammed human iPSC-derived glutamatergic neurons in their experiments. Download now.

article thumbnail

Forge Biologics joins BGTC for new AAV gene therapies development

Pharmaceutical Technology

The tools and resources for clinical development, particularly large-scale platform cGMP [current good manufacturing practice] manufacturing and regulatory evaluation of AAV therapies, will provide a much-needed standardised approach, enabling meaningful progress for rare disease gene therapy development.

article thumbnail

July 10, 2023: EHR Core’s Keith Marsolo Shares Scientific Goals and Resources Needed For Data Sharing

Rethinking Clinical Trials

Most studies have only had one or two requests for data. Study teams can be more upfront about the data and metadata that can be shared and the use cases they can support,” Marsolo said. With regards to resources needed for data sharing, Marsolo stated, “There might be funding that needs to be allocated to promote data sharing.

Trials 130
article thumbnail

March 23, 2023: AJOB Calls for Peer Commentaries on Ethics in Pragmatic Trials

Rethinking Clinical Trials

After presenting three case studies from recent pragmatic clinical trials, we identify six differences between explanatory trials and embedded research that limit the application of existing scholarship for ascertaining investigator duties. However, it also has presented ethical challenges.

Trials 189
article thumbnail

PAN-TB’s Phase II trials take a shot at shorter TB regimens

Pharmaceutical Technology

As per the Institute for Health Metrics and Evaluation, TB incidence has massively reduced globally in the last few decades, with a fall from 164 cases per 100,000 people in 1990 to 109 cases per 100,000 individuals in 2019. This fall in TB cases and deaths has been a direct consequence of global efforts to make TB endemic.

Trials 246